On Wednesday, the MEPs of the ITRE Committee in the EU Parliament will vote on the compromise proposals for the ETS and CBAM. The compromise is supported by conservatives, social democrats, and liberals – but not by the Greens.
By Lukas Knigge
The EU Commission intends to revise European pharmaceutical legislation at the end of 2022. Even during the consultations at the end of 2021, the pharmaceutical industry did not see any fundamental need for improvement. However, now, it is taking the plunge and presenting its own proposals to make access to medicines faster and fairer for millions of patients in the EU.
By Eugenie Ankowitsch